Article Text

OP0037 First Pilot Study of An Implantable Loop Recorder (ILR) in Systemic Sclerosis Detects Significant Cardiac Arrhythmias with CMR Abnormalities
  1. L.-A. Bissell1,2,
  2. R. Dumitru1,2,
  3. B. Erhayiem3,
  4. G. Fent3,
  5. J.P. Greenwood3,
  6. S. Plein3,
  7. J. Andrews1,2,
  8. L. Graham3,
  9. M.H. Buch1,2
  2. 2LIRMM
  3. 3LIGHT, University of Leeds, Leeds, United Kingdom


Background SSc-cardiomyopathy associated conduction abnormalities carry a poor prognosis, but their pathogenesis is unclear. Early detection to prevent complications is essential. ILRs are well-established in cardiology practice.

Objectives To determine the spectrum of cardiac conduction abnormalities (CCA) using the REVEAL® ILR & their association with CMR in patients (pts) with SSc with no known cardiac disease.

Methods 20 pts with (ACR/EULAR criteria) SSc, with no diabetes &/or more than 1 cardiovascular (CV) risk factor, were assessed for SSc/CV profile & comprehensive CV assessment performed, inc. 3T delayed enhancement-CMR (reported by CMR-cardiologists) & ILR insertion. ILR data was downloaded 3 monthly +/− at pt request if indicated. One yr data is reported. CMR compared to 30 healthy controls.

Results ILR data was available for 19 pts; 63% female, 84% Caucasian; mean (SD) age 53 (12)yrs, time from 1st non-RP symptom 9 (8)yrs; 32% dcSSc, 32% ACA+ve, 21% Scl70+ve, 54% palpitations hx, 42% known ILD, 11% DU hx, 0% pulmonary hypertension. Ten (52%) pts had ILR abnormalities; 4 with dcSSc, 3 ACA+ve, 3 Scl70+ve, 6 with palpitations hx, 4 known ILD, 3 DU hx. Subanalysis; 8 (42%) pts had supraventricular ectopics (SVE), 2 (11%) with ventricular ectopics (VE), 4 (21%) with arrhythmias of which 1 atrial flutter, 1 SVT, 1 VT & 1 complete heart block (CHB). Of the 4 pts with arrhythmias; 2 had dcSSc, 1 ACA+ve, 1 Scl70, 3 palpitations hx, 2 known ILD, 2 DU hx. Pt with CHB (dcSSc) had few SVE/VEs & 3 couplets on 24hr ECG 6 weeks previous. CMR data was available for 15 SSc pts (DE in 14; 1 pt claustrophobic, no IV access in 2, 1 CMR abandoned due to pacemaker insertion for CHB). Trend towards lower LVmass & distensibility (ie greater arterial stiffness) & higher extracellular volume (ECV, fibrosis marker) seen in pts with ILR abnormalities (p>0.05). Trend for higher ECV in those with SVE [unadj. mean difference (diff.) (95%CI) 1.1 (-2.5, 4.7)% p0.513], VE [0.7 (-4.9, 6.3)% p0.789] & arrhythmias [1.8 (-3.7, 7.3)% p0.486]. ECV was higher in SSc vs. controls; mean diff. 4.9 (3.2, 6.6)% p<0.001 R2 0.568, adj. for age/sex; with trend for lower LV mass & distensibility.

Table 1.

CMR measures in SSc pts with/without ILR abnormalities

Conclusions This first ILR in SSc study demonstrates its utility in the incidental detection of CCA, including serious cardiac arrhythmias & suggests associated CMR abnormalities. These data support the need for identification of pts at risk that would benefit from ILR & provide insights into the pathogenesis of SSc-cardiomyopathy

Disclosure of Interest None declared

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.